TLR4-NOX4-AP-1 signaling mediates lipopolysaccharide-induced CXCR6 expression in human aortic smooth muscle cells
Journal Article
·
· Biochemical and Biophysical Research Communications
- Department of Veterans Affairs South Texas Veterans Health Care System, San Antonio, TX (United States)
- Critical Care Medicine Department, Clinical Center, NIH, Bethesda, MD (United States)
- Department of Medicine, Jefferson Medical College of Thomas Jefferson University, Philadelphia, PA (United States)
- Imperial College of Science, Technology and Medicine, London (United Kingdom)
- Division of Biomedical Sciences, University of California at Riverside, Riverside, CA (United States)
- Department of Surgery, University of Massachusetts, Worcester, MA (United States)
- Department of Veterans Affairs South Texas Veterans Health Care System, San Antonio, TX (United States) and Department of Veterans Affairs South Texas Veterans Health Care System, San Antonio, TX (United States)
CXCL16 is a transmembrane non-ELR CXC chemokine that signals via CXCR6 to induce aortic smooth muscle cell (ASMC) proliferation. While bacterial lipopolysaccharide (LPS) has been shown to stimulate CXCL16 expression in SMC, its effects on CXCR6 are not known. Here, we demonstrate that LPS upregulates CXCR6 mRNA, protein, and surface expression in human ASMC. Inhibition of TLR4 with neutralizing antibodies or specific siRNA interference blocked LPS-mediated CXCR6 expression. LPS stimulated both AP-1 (c-Fos, c-Jun) and NF-{kappa}B (p50 and p65) activation, but only inhibition of AP-1 attenuated LPS-induced CXCR6 expression. Using dominant negative expression vectors and siRNA interference, we demonstrate that LPS induces AP-1 activation via MyD88, TRAF6, ERK1/2, and JNK signaling pathways. Furthermore, the flavoprotein inhibitor diphenyleniodonium chloride significantly attenuated LPS-mediated AP-1-dependent CXCR6 expression, as did inhibition of NOX4 NADPH oxidase by siRNA. Finally, CXCR6 knockdown inhibited CXCL16-induced ASMC proliferation. These results demonstrate that LPS-TLR4-NOX4-AP-1 signaling can induce CXCR6 expression in ASMC, and suggest that the CXCL16-CXCR6 axis may be an important proinflammatory pathway in the pathogenesis of atherosclerosis.
- OSTI ID:
- 20854452
- Journal Information:
- Biochemical and Biophysical Research Communications, Journal Name: Biochemical and Biophysical Research Communications Journal Issue: 4 Vol. 347; ISSN BBRCA9; ISSN 0006-291X
- Country of Publication:
- United States
- Language:
- English
Similar Records
TLR4 induces CREB-mediated IL-6 production via upregulation of F-spondin to promote vascular smooth muscle cell migration
CXC195 suppresses proliferation and inflammatory response in LPS-induced human hepatocellular carcinoma cells via regulating TLR4-MyD88-TAK1-mediated NF-κB and MAPK pathway
Lipopolysaccharide induces proliferation and osteogenic differentiation of adipose-derived mesenchymal stromal cells in vitro via TLR4 activation
Journal Article
·
Fri May 13 00:00:00 EDT 2016
· Biochemical and Biophysical Research Communications
·
OSTI ID:22598720
CXC195 suppresses proliferation and inflammatory response in LPS-induced human hepatocellular carcinoma cells via regulating TLR4-MyD88-TAK1-mediated NF-κB and MAPK pathway
Journal Article
·
Thu Jan 01 23:00:00 EST 2015
· Biochemical and Biophysical Research Communications
·
OSTI ID:22416886
Lipopolysaccharide induces proliferation and osteogenic differentiation of adipose-derived mesenchymal stromal cells in vitro via TLR4 activation
Journal Article
·
Sat Dec 31 23:00:00 EST 2016
· Experimental Cell Research
·
OSTI ID:22649803